Benefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
Stroke patients with normal, but not those with impaired, renal function have greater benefit with ticagrelor-aspirin than clopidogrel-aspirin
Source: empr.com
Salubris Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Salubris Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Salubris Pharmaceuticals Today - Breaking & Trending Today
Benefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
Among CYP2C19 loss-of-function allele carriers with minor stroke or transient ischemic attack, those with normal renal function rather than impaired renal function derive greater benefit from ticagrelor-aspirin versus clopidogrel-aspirin.
Source: neurologyadvisor.com
Week In Review: VectorBuilder Raises $57 Million For Gene Therapy Delivery CDMO
Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.
Source: seekingalpha.com